Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 3 7Phase 1/2 3Phase 2/3 2Phase 1 2

Status

Completed 6Terminated 1

Sponsor Class

INDUSTRY 4NETWORK 3

Study Type

Interventional 7

Sponsor

Cancer Type

Genitourinary 7

Conditions

Leukemia, Myeloid, Acute 22Leukemia 15Lymphoma 11Leukemia, Erythroblastic, Acute 8Prostatic Neoplasms 7Leukemia, Myelomonocytic, Acute 7Leukemia, Monocytic, Acute 7Leukemia, Megakaryoblastic, Acute 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Anemia, Refractory, with Excess of Blasts 4Leukemia, Promyelocytic, Acute 3Congenital Abnormalities 3Breast Neoplasms 3Pain 2Neutropenia 2Myeloproliferative Disorders 2Leukemia, Myelomonocytic, Chronic 2Burkitt Lymphoma 2Sarcoma, Myeloid 1Recurrence 1Ovarian Neoplasms 1Neoplasms 1Neoplasm, Residual 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

Prednisone 53Radiotherapy 52Docetaxel 51Leuprolide 48Goserelin 47bicalutamide 45enzalutamide 28acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 27Androgen Antagonists 27Flutamide 24Triptorelin Pamoate 22apalutamide 18Gonadotropin-Releasing Hormone 18Abiraterone Acetate 17Radiation 15abiraterone 14Zoledronic Acid 14Magnetic Resonance Spectroscopy 13gallium 68 PSMA-11 12Prednisolone 11luprolide acetate gel depot 10darolutamide 9Radiosurgery 9cabazitaxel 8Standard of Care 8Specimen Handling 8Radiotherapy, Intensity-Modulated 8Radiotherapy, Conformal 8Estramustine 8Dexamethasone 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 3 × Prostatic Neoplasms × Mitoxantrone × Clear all
NCT00004124 2022-12-30

S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

SWOG Cancer Research Network

Phase 3 Completed
983 enrolled 13 charts
Genitourinary

Prostatic Neoplasms

NCT00003232 2020-04-03

Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer

Canadian Cancer Trials Group

Phase 3 Completed
227 enrolled
Genitourinary

Pain, Prostatic Neoplasms

NCT01522443 2018-05-23

COMET-2

Exelixis

Phase 3 Terminated
119 enrolled 21 charts
Genitourinary

Pain, Prostatic Neoplasms

NCT00004001 2014-02-25

S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

SWOG Cancer Research Network

Phase 3 Completed
770 enrolled
Genitourinary

Prostatic Neoplasms

NCT00003343 2012-08-08

Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer

Pfizer

Phase 3 Completed
525 enrolled
Genitourinary

Prostatic Neoplasms

NCT00436839 2012-07-09

Taxotere Prostate Cancer New Indication Registration Trial in China

Sanofi

Phase 3 Completed
228 enrolled
Genitourinary

Prostatic Neoplasms

NCT00417079 2011-03-10

TROPIC

Sanofi

Phase 3 Completed
755 enrolled 19 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡